Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BIO-TECHNE (TECH) FCF Margin: 2009-2025

Historic FCF Margin for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to 7.75%.

  • BIO-TECHNE's FCF Margin fell 1115.00% to 7.75% in Q3 2025 from the same period last year, while for Sep 2025 it was 18.41%, marking a year-over-year decrease of 250.00%. This contributed to the annual value of 21.03% for FY2025, which is 66.00% up from last year.
  • Latest data reveals that BIO-TECHNE reported FCF Margin of 7.75% as of Q3 2025, which was down 73.66% from 29.44% recorded in Q2 2025.
  • BIO-TECHNE's 5-year FCF Margin high stood at 2,326.25% for Q3 2022, and its period low was 7.75% during Q3 2025.
  • For the 3-year period, BIO-TECHNE's FCF Margin averaged around 19.17%, with its median value being 18.90% (2024).
  • In the last 5 years, BIO-TECHNE's FCF Margin surged by 230,981bps in 2022 and then crashed by 230,972bps in 2023.
  • BIO-TECHNE's FCF Margin (Quarterly) stood at 33.73% in 2021, then slumped by 1,227bps to 21.46% in 2022, then surged by 358bps to 25.04% in 2023, then skyrocketed by 106bps to 26.10% in 2024, then crashed by 1,115bps to 7.75% in 2025.
  • Its last three reported values are 7.75% in Q3 2025, 29.44% for Q2 2025, and 9.80% during Q1 2025.